BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Serras AS, Rodrigues JS, Cipriano M, Rodrigues AV, Oliveira NG, Miranda JP. A Critical Perspective on 3D Liver Models for Drug Metabolism and Toxicology Studies. Front Cell Dev Biol 2021;9:626805. [PMID: 33732695 DOI: 10.3389/fcell.2021.626805] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Fernandez-Checa JC, Bagnaninchi P, Ye H, Sancho-Bru P, Falcon-Perez JM, Royo F, Garcia-Ruiz C, Konu O, Miranda J, Lunov O, Dejneka A, Elfick A, McDonald A, Sullivan GJ, Aithal G, Lucena MI, Andrade RJ, Fromenty B, Krannendonk M, Cubero FJ, Nelson LJ. ADVANCED PRECLINICAL MODELS FOR EVALUATION OF DRUG INDUCED LIVER INJURY - CONSENSUS STATEMENT BY THE EUROPEAN DRUG-INDUCED LIVER INJURY NETWORK [PRO-EURO-DILI-NET]. J Hepatol 2021:S0168-8278(21)00441-4. [PMID: 34171436 DOI: 10.1016/j.jhep.2021.06.021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 Youhanna S, Kemas AM, Preiss L, Zhou Y, Shen JX, Cakal SD, Paqualini FS, Goparaju SK, Shafagh RZ, Lind JU, Sellgren CM, Lauschke VM. Organotypic and Microphysiological Human Tissue Models for Drug Discovery and Development-Current State-of-the-Art and Future Perspectives. Pharmacol Rev 2022;74:141-206. [PMID: 35017176 DOI: 10.1124/pharmrev.120.000238] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Janani G, Priya S, Dey S, Mandal BB. Mimicking Native Liver Lobule Microarchitecture In Vitro with Parenchymal and Non-parenchymal Cells Using 3D Bioprinting for Drug Toxicity and Drug Screening Applications. ACS Appl Mater Interfaces 2022;14:10167-86. [PMID: 35171571 DOI: 10.1021/acsami.2c00312] [Reference Citation Analysis]
4 Yan L, Messner CJ, Tian M, Gou X, Suter-Dick L, Zhang X. Evaluation of dioxin induced transcriptomic responses in a 3D human liver microtissue model. Environ Res 2022;:112906. [PMID: 35181307 DOI: 10.1016/j.envres.2022.112906] [Reference Citation Analysis]
5 Tricot T, Verfaillie CM, Kumar M. Current Status and Challenges of Human Induced Pluripotent Stem Cell-Derived Liver Models in Drug Discovery. Cells 2022;11:442. [DOI: 10.3390/cells11030442] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
6 Schofield CA, Walker TM, Taylor MA, Patel M, Vlachou DF, Macina JM, Vidgeon-Hart MP, Williams A, McGill PJ, Newman CF, Sakatis MZ. Evaluation of a Three-Dimensional Primary Human Hepatocyte Spheroid Model: Adoption and Industrialization for the Enhanced Detection of Drug-Induced Liver Injury. Chem Res Toxicol 2021. [PMID: 34797640 DOI: 10.1021/acs.chemrestox.1c00227] [Reference Citation Analysis]
7 Mirahmad M, Sabourian R, Mahdavi M, Larijani B, Safavi M. In vitro cell-based models of drug-induced hepatotoxicity screening: progress and limitation. Drug Metab Rev 2022;:1-76. [PMID: 35403528 DOI: 10.1080/03602532.2022.2064487] [Reference Citation Analysis]
8 Hernandez-Jerez AF, Adriaanse P, Aldrich A, Berny P, Coja T, Duquesne S, Focks A, Marinovich M, Millet M, Pelkonen O, Pieper S, Tiktak A, Topping CJ, Widenfalk A, Wilks M, Wolterink G, Gundert-Remy U, Louisse J, Rudaz S, Testai E, Lostia A, Dorne JL, Parra Morte JM; EFSA Panel on Plant Protection Products and their Residues (EFSA PPR Panel). Scientific Opinion of the Scientific Panel on Plant Protection Products and their Residues (PPR Panel) on testing and interpretation of comparative in vitro metabolism studies. EFSA J 2021;19:e06970. [PMID: 34987623 DOI: 10.2903/j.efsa.2021.6970] [Reference Citation Analysis]
9 Donato MT, Jiménez N, Pelechá M, Tolosa L. Oxidative-stress and long-term hepatotoxicity: comparative study in Upcyte human hepatocytes and hepaRG cells. Arch Toxicol 2022. [PMID: 35156134 DOI: 10.1007/s00204-022-03236-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Kobets T, Duan JD, Vock E, Deschl U, Williams GM. Evaluation of Pharmaceuticals for DNA Damage in the Chicken Egg Genotoxicity Assay (CEGA). Int J Toxicol 2022;:10915818221093583. [PMID: 35658642 DOI: 10.1177/10915818221093583] [Reference Citation Analysis]
11 Pasqua M, Di Gesù R, Chinnici CM, Conaldi PG, Francipane MG. Generation of Hepatobiliary Cell Lineages from Human Induced Pluripotent Stem Cells: Applications in Disease Modeling and Drug Screening. Int J Mol Sci 2021;22:8227. [PMID: 34360991 DOI: 10.3390/ijms22158227] [Reference Citation Analysis]
12 Yadav J, El Hassani M, Sodhi J, Lauschke VM, Hartman JH, Russell LE. Recent developments in in vitro and in vivo models for improved translation of preclinical pharmacokinetics and pharmacodynamics data. Drug Metab Rev 2021;53:207-33. [PMID: 33989099 DOI: 10.1080/03602532.2021.1922435] [Reference Citation Analysis]
13 Lubamba B, Jensen T, Mcclelland R. Rapid Detection of Direct Compound Toxicity and Trailing Detection of Indirect Cell Metabolite Toxicity in a 96-Well Fluidic Culture Device for Cell-Based Screening Environments: Tactics in Six Sigma Quality Control Charts. Applied Sciences 2022;12:2786. [DOI: 10.3390/app12062786] [Reference Citation Analysis]
14 Shroff T, Aina K, Maass C, Cipriano M, Lambrecht J, Tacke F, Mosig A, Loskill P. Studying metabolism with multi-organ chips: new tools for disease modelling, pharmacokinetics and pharmacodynamics. Open Biol 2022;12:210333. [PMID: 35232251 DOI: 10.1098/rsob.210333] [Reference Citation Analysis]
15 Sasikumar S, Boden A, Chameettachal S, Cipolla L, Cromer B, Kingshott P, Pati F. Galactose Tethered Decellularized Liver Matrix: Toward a Biomimetic and Biofunctional Matrix for Liver Tissue Engineering. ACS Appl Bio Mater 2022. [PMID: 35548974 DOI: 10.1021/acsabm.2c00330] [Reference Citation Analysis]
16 Segovia-Zafra A, Di Zeo-Sánchez DE, López-Gómez C, Pérez-Valdés Z, García-Fuentes E, Andrade RJ, Lucena MI, Villanueva-Paz M. Preclinical models of idiosyncratic drug-induced liver injury (iDILI): Moving towards prediction. Acta Pharm Sin B 2021;11:3685-726. [PMID: 35024301 DOI: 10.1016/j.apsb.2021.11.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]